250 related articles for article (PubMed ID: 23448394)
1. Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection.
Du WJ; Zhen JH; Zeng ZQ; Zheng ZM; Xu Y; Qin LY; Chen SJ
Diagn Pathol; 2013 Feb; 8():40. PubMed ID: 23448394
[TBL] [Abstract][Full Text] [Related]
2. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
3. Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection.
Tian CH; Dai J; Zhang W; Liu Y; Yang Y
Medicine (Baltimore); 2019 Jun; 98(23):e15924. PubMed ID: 31169710
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α-induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection.
Liu Y; Jin J; Ji J; Gao XM; Fan YC
Virol J; 2019 Oct; 16(1):120. PubMed ID: 31661000
[TBL] [Abstract][Full Text] [Related]
5. [Expression of interleukin-17 in hepatitis B related liver fibrosis].
Xu Y; DU WJ; Qin LY; Xing ZZ; Qin XH; Chen SJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):133-5. PubMed ID: 19174010
[TBL] [Abstract][Full Text] [Related]
6. Relationship between expression of toll-like receptors 2/4 in dendritic cells and chronic hepatitis B virus infection.
Lu X; Xu Q; Bu X; Ma X; Zhang F; Deng Q; Zhang Y; Ding J
Int J Clin Exp Pathol; 2014; 7(9):6048-55. PubMed ID: 25337250
[TBL] [Abstract][Full Text] [Related]
7. Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients.
Kao JT; Lai HC; Tsai SM; Lin PC; Chuang PH; Yu CJ; Cheng KS; Su WP; Hsu PN; Peng CY; Wu YY
Liver Int; 2012 Jul; 32(6):928-36. PubMed ID: 22230324
[TBL] [Abstract][Full Text] [Related]
8. Increased Proinflammatory Cytokine Production by Chronic Hepatitis B Patients with Mutant Hepatitis B Virus: Plausible Mechanisms Underlying Severe Liver Diseases in These Patients.
Raihan R; Akbar SMF; Al Mahtab M; Khan MSI; Tabassum S; Tee KK; Mohamed RB
Viral Immunol; 2020 Sep; 33(7):530-534. PubMed ID: 32513066
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.
Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K
Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895
[TBL] [Abstract][Full Text] [Related]
10. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
11. IL28B is associated with outcomes of chronic HBV infection.
Shi X; Chi X; Pan Y; Gao Y; Li W; Yang C; Zhong J; Xu D; Zhang M; Minuk G; Jiang J; Niu J
Yonsei Med J; 2015 May; 56(3):625-33. PubMed ID: 25837166
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
[TBL] [Abstract][Full Text] [Related]
13. Enhanced levels of interleukin-8 are associated with hepatitis B virus infection and resistance to interferon-alpha therapy.
Yang K; Guan SH; Zhang H; Pan Y; Wu YY; Wang AH; Sun BB
Int J Mol Sci; 2014 Nov; 15(11):21286-98. PubMed ID: 25407531
[TBL] [Abstract][Full Text] [Related]
14. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
[TBL] [Abstract][Full Text] [Related]
15. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.
Yu X; Guo R; Ming D; Su M; Lin C; Deng Y; Lin Z; Su Z
J Gastroenterol Hepatol; 2014 May; 29(5):1065-72. PubMed ID: 24236690
[TBL] [Abstract][Full Text] [Related]
16. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis.
Piao RL; Brigstock DR; Zhu J; Zhang ML; Gao RP
World J Gastroenterol; 2012 May; 18(18):2280-6. PubMed ID: 22611323
[TBL] [Abstract][Full Text] [Related]
19. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
20. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis.
Sun HQ; Zhang JY; Zhang H; Zou ZS; Wang FS; Jia JH
J Viral Hepat; 2012 Jun; 19(6):396-403. PubMed ID: 22571901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
